TuHURA Biosciences (HURA) Total Liabilities (2011 - 2026)

TuHURA Biosciences' Total Liabilities history runs 16 years deep, the most recent figure standing at $6.5 million for Q1 2026.

• On a quarterly basis, Total Liabilities rose 36.23% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 36.23% increase from a year earlier, with the FY2025 full-year figure at $6.4 million, up 19.51% from the prior year.
• Total Liabilities improved to $6.5 million in Q1 2026 per HURA's latest filing, from $6.4 million in the prior quarter.
• Across five years, Total Liabilities topped out at $15.2 million in Q2 2025 and bottomed at $1.5 million in Q1 2024.
• The 5-year median for Total Liabilities is $3.6 million (2022), against an average of $4.9 million.
• Across the five-year window, Total Liabilities plunged 48.41% in 2024 and soared 520.52% in 2025, its largest moves.
• Year by year, Total Liabilities stood at $3.3 million in 2022, then surged by 78.38% to $5.9 million in 2023, then retreated by 9.25% to $5.4 million in 2024, then gained by 19.51% to $6.4 million in 2025, then gained by 1.47% to $6.5 million in 2026.
• Per Business Quant, the three latest HURA Total Liabilities figures stand at $6.5 million (Q1 2026), $6.4 million (Q4 2025), and $8.9 million (Q3 2025).